Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹3,925 Cr₹2,435 Cr₹2,387 Cr₹5,016 Cr₹3,329 Cr

What is the latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA is ₹3,925 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹3,925 Cr
Mar2024₹2,435 Cr
Mar2023₹2,387 Cr
Mar2022₹5,016 Cr
Mar2021₹3,329 Cr

How is Cash Flow from Operating Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹3,925 Cr
61.21
Mar2024 ₹2,435 Cr
2.00
Mar2023 ₹2,387 Cr
-52.42
Mar2022 ₹5,016 Cr
50.69
Mar2021 ₹3,329 Cr -

Compare Cash Flow from Operating Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹77,949.2 Cr 1.9% 7.4% 8.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,713.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹156,811.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,052.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,927.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹96,602.7 Cr 0% -9.1% -18.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.9%

7.4%

8.6%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses